| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Finke Thomas M | Director | C/O VENU HOLDING CORPORATION, 1755 TELSTAR DRIVE, SUITE 501, COLORADO SPRINGS | /s/ Heather Atkinson, as attorney-in-fact for Thomas Finke | 30 Oct 2025 | 0001363651 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VENU | Stock Option (Right to Buy) | Award | $0 | +250,000 | $0 | 250,000 | 28 Oct 2025 | Common Stock | 250,000 | $10 | Direct | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | This option was approved by the board of directors (the "Board") of Venu Holding Corporation (the "Issuer") and is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d)(1) promulgated thereunder. |
| F2 | This option grant was approved by the Issuer's Board on May 1, 2025, subject to shareholder approval of an amendment to the Issuer's Amended and Restated 2023 Omnibus Incentive Compensation Plan (the "Plan"), which the option was granted under, to increase the number of shares of the Company's common stock (the "Common Stock") reserved for issuance under the Plan. The Issuer's shareholders approved such amendment to the Plan on October 28, 2025 (the "Grant Effective Date"). |
| F3 | Of the 250,000 shares of Common Stock underlying this option, 50,000 shares vested immediately on the Grant Effective Date. Thereafter, 50,000 shares will vest on each annual anniversary of the effective date of the Reporting Person's appointment to the Board, which occurred on May 5, 2025. |